Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06472206 · ClinicalTrials.gov registry record · NA

Community Health Workers And MHealth to ImProve Viral Suppression Plus (CHAMPS+)

A NA study of HIV/AIDS, sponsored by Columbia University.

Recruiting
Registry status
NA
Development phase
420
Enrollment target
5
Study locations

NCT06472206 is a NA study of HIV/AIDS that is actively recruiting participants, run by Columbia University. The registered enrollment target is 420 participants, below the 33,174-participant average among 61 other HIV/AIDS trials with a reported enrollment target (99% lower). The trial reports 5 study locations across 3 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06472206, a NA study of HIV/AIDS, is actively recruiting participants, sponsored by Columbia University.

RECRUITING
Registry status
NA
Development phase
420 participants
Enrollment target
5
Study locations

Study Summary

Although global efforts have been made to end the HIV epidemic, there are still some gaps in HIV testing, antiretroviral therapy (ART) adherence, and viral suppression (VS) among people with HIV (PWH). These gaps are particularly prominent in the Deep South of the United States (US), where PWH face challenges in accessing healthcare services. In response, a team of experienced researchers has developed and tested the Community Health Workers And MHealth to ImProve Viral Suppression (CHAMPS) intervention. This intervention uses mobile health (mHealth) technology and a team of community health workers (CHW) to design an intervention to improve ART adherence and VS. The CHAMPS+ intervention adds a CHW delivered supportive risk reduction counseling during periods of non-suppression to prevent HIV transmission. The study will engage the participants by developing culturally relevant materials and retention strategies, evaluating the clinical effectiveness and sustainability of the intervention in Deep South settings, and assessing regionalized implementation factors. Ultimately, the study will test the effectiveness of CHAMPS+ on ART adherence and viral load suppression for PWH in Alabama, Louisiana, and Mississippi.

Conditions Studied

Interventions

  • DEVICE CleverCap
  • BEHAVIORAL CHW Sessions

Study Locations (5)

Alabama

  • Health Services Center, Inc. - Hobson City
  • Unity Wellness Center - Opelika

Louisiana

  • Louisiana State University Health Sciences Center in New Orleans - New Orleans
  • Tulane University - New Orleans

Mississippi

  • University of Mississippi Medical Center - Jackson

Trial Details

FieldValue
Enrollment Target 420 participants
Start Date 2024-09-23
Est. Completion 2027-12-22
Phase NA

Sponsor

Columbia University

958 total trials

What the Registry Record Tells You About NCT06472206

The ClinicalTrials.gov registry entry for NCT06472206 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 420 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 33,174-participant average among 61 other HIV/AIDS trials with a reported enrollment target (99% lower). The listed sponsor is Columbia University, which has 958 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with HIV/AIDS appearing as the primary indexed condition, and to 2 interventions - of which CleverCap is the first listed.

NCT06472206 reports 5 study locations spanning 3 distinct geographic areas - top geographies include Alabama, Louisiana, Mississippi.

Frequently Asked Questions

What is clinical trial NCT06472206 about?

NCT06472206 is a clinical study titled "Community Health Workers And MHealth to ImProve Viral Suppression Plus (CHAMPS+)". Although global efforts have been made to end the HIV epidemic, there are still some gaps in HIV testing, antiretroviral therapy (ART) adherence, and viral suppression (VS) among people with HIV (PWH). These gaps are particularly prominent in the Deep South of the United States (US), where PWH face ...

What is the current status of trial NCT06472206?

This trial is currently recruiting. It is a NA study. The enrollment target is 420 participants. The study started on 2024-09-23. Estimated completion is 2027-12-22.

What conditions does trial NCT06472206 study?

This clinical trial studies the following conditions: HIV/AIDS.

What interventions are being tested in trial NCT06472206?

The interventions under investigation include: CleverCap (DEVICE), CHW Sessions (BEHAVIORAL).

Who is sponsoring clinical trial NCT06472206?

This trial is sponsored by Columbia University, which has 958 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06472206 being conducted?

This trial has 5 study locations across Alabama, Louisiana, Mississippi. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for HIV/AIDS

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.